Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Mini Review - (2023) Volume 17, Issue 7

Cell Therapy Advancements for Immunological Conditions

Odam SG* and Shippman J
Health science and technology, Radboud University Nijmegen, Netherlands
*Correspondence: Odam SG, Health science and technology, Radboud University Nijmegen, Netherlands, Email:

Received: 01-Jul-2023, Manuscript No. Iphsj-23-13982; Editor assigned: 03-Jul-2023, Pre QC No. Iphsj-23-13982 (PQ); Reviewed: 17-Jul-2023, QC No. Iphsj-23-13982; Revised: 23-Jul-2023, Manuscript No. Iphsj-23-13982(R); Published: 31-Jul-2023, DOI: 10.36648/1791- 809X.17.7.1042


Cell therapy has emerged as a ground-breaking approach in the field of immunology, presenting new opportunities for the treatment of various immunological conditions. This innovative therapeutic strategy involves utilizing living cells to enhance or suppress the immune response, depending on the specific disease being targeted. In this abstract, we explore the applications of cell therapy in immunological disorders, including autoimmune diseases, cancer immunotherapy, immunodeficiencies, allergic disorders, and transplantation. Specifically, we discuss the use of regulatory T-cells (Tregs) to suppress autoimmunity, chimeric antigen receptor T-cell (CAR-T) therapy for cancer treatment, and hematopoietic stem cell transplantation (HSCT) for immunodeficiencies. Furthermore, we highlight the challenges associated with cell therapy, including safety concerns, personalized approaches, cost, and long-term efficacy. Despite these challenges, cell therapy holds great promise, paving the way for transformative advancements in immunology and offering hope for improved treatment outcomes and potential cures for patients with immunological conditions. Continued research and development in this area will undoubtedly shape the future of immunology and pave the way for personalized, effective, and accessible cell-based treatments.


Cell therapy; Immunology; Autoimmune disorders; Cancer immunotherapy; Regulatory T-Cells; Chimeric antigen receptor T-Cells (CAR-T); Hematopoietic stem cell transplantation (HSCT); Immunodeficiency


The human immune system is a complex network of cells, tissues, and molecules that work in unison to protect the body against infections, diseases, and foreign invaders. However, sometimes this intricate system malfunctions, leading to various immunological conditions, including autoimmune disorders, immunodeficiencies, and allergic reactions. Conventional treatments for such conditions often involve medications that suppress the immune response, but they may come with side effects and offer limited efficacy. In recent years [1-3], cell therapy has emerged as a promising avenue to revolutionize the field of immunology, offering hope for improved treatment outcomes and potential cures.

Understanding cell therapy

Cell therapy is an innovative approach that involves the use of living cells to treat medical conditions. In the context of immunology, it aims to harness the potential of immune cells to either enhance or suppress the immune response, depending on the specific condition being targeted. These cells can be sourced from the patient's own body (autologous) or from a donor (allogeneic).

Types of cell therapy for immunology

Adoptive T-cell therapy: This type of cell therapy involves the isolation and expansion of T-cells, a vital component of the immune system responsible for recognizing and eliminating infected or abnormal cells. T-cells can be genetically engineered to express chimeric antigen receptors (CAR-T cells) that target specific antigens found on cancer cells, providing a revolutionary treatment for certain types of blood cancers [4, 5].

Regulatory T-cell therapy: Regulatory T-cells (Tregs) play a crucial role in maintaining immune homeostasis by suppressing excessive immune responses. By harnessing the immunosuppressive properties of Tregs, researchers are exploring their potential to treat autoimmune disorders and prevent transplant rejection.

Hematopoietic stem cell transplantation (HSCT): HSCT involves the transplantation of stem cells derived from the bone marrow, peripheral blood, or umbilical cord blood. It is commonly used to treat certain immunodeficiencies and autoimmune diseases. The procedure aims to "reset" the immune system by replacing faulty immune cells with healthy ones.

Natural Killer (NK) cell therapy: NK cells are a type of innate immune cell known for their ability to recognize and destroy infected or cancerous cells without prior sensitization. Researchers are investigating their potential as a targeted therapy for certain cancers and viral infections.

Promising applications in immunological conditions

Cancer immunotherapy: CAR-T cell therapy has shown remarkable success in treating certain hematologic malignancies, such as acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma. On-going research aims to expand its application to solid Tumors, offering a potentially curative treatment option for previously untreatable cancers [6].

Autoimmune disorders: Cell therapy presents a novel approach to address autoimmune conditions like rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. By modulating the immune response with regulatory T-cells or other immunemodulating cells, researchers hope to induce tolerance to selfantigens and halt the progression of these diseases.

Immunodeficiency: In cases of severe combined immunodeficiency (SCID) and other primary immunodeficiency’s, HSCT has shown promise in restoring proper immune function and offering affected individuals a chance at a more normal life [7].

Challenges and future directions

While cell therapy holds tremendous potential for revolutionizing immunology, several challenges must be addressed to ensure its safe and effective implementation:

Safety concerns: Cell therapy can trigger severe immune reactions, including cytokine release syndrome, graft-versus-host disease (GVHD), and neurotoxicity. Researchers are continually refining the techniques to minimize these risks.

Cost and accessibility: Cell therapy is currently expensive and complex, limiting its availability to a broader population. Ongoing research aims to streamline manufacturing processes and reduce costs.

Long-term outcomes: Understanding the long-term effects of cell therapy is critical, especially for its application in chronic immunological conditions

Cell therapy has shown significant promise as a revolutionary approach in the field of immunology. It involves the use of living cells to either enhance or suppress the immune response, depending on the specific condition being treated. Let's delve deeper into the discussion of cell therapy and its applications in various immunological conditions [8].

Autoimmune disorders

Autoimmune disorders occur when the immune system mistakenly attacks its host's healthy tissues, leading to chronic inflammation and tissue damage. Cell therapy aims to address these conditions by utilizing regulatory T-cells (Tregs) to suppress the immune response. Tregs play a crucial role in maintaining immune tolerance and preventing excessive immune reactions. By increasing the number or activity of Tregs, researchers hope to control the immune response, halt the progression of autoimmune diseases, and induce tolerance to self-antigens.

Cancer immunotherapy

One of the most significant breakthroughs in cell therapy for immunology is CAR-T cell therapy, primarily used in the treatment of certain blood cancers. CAR-T cells are genetically engineered T-cells that express chimeric antigen receptors, allowing them to target specific antigens found on cancer cells. When infused back into the patient, these modified CAR-T cells can effectively recognize and eliminate cancer cells. This innovative therapy has shown remarkable success in patients with refractory or relapsed leukaemia and lymphoma, leading to long-lasting remissions and, in some cases, potential cures [9].


Primary immunodeficiency is genetic disorders characterized by defects in the immune system, making patients highly susceptible to infections. In severe combined immunodeficiency (SCID), for example, patients lack functional T-cells and B-cells. Hematopoietic stem cell transplantation (HSCT) is a form of cell therapy that can restore the immune system by providing healthy stem cells to replace the defective ones. HSCT has proven to be a life-saving treatment for children born with SCID and other severe immunodeficiency’s, offering them a chance at a functional immune system and improved quality of life.

Allergic disorders

Cell therapy is also being explored as a potential treatment for allergic conditions, such as severe allergic asthma and food allergies. Researchers are investigating the use of modified T-cells or other immune cells to desensitize the immune response to specific allergens, reducing allergic reactions and providing relief to affected individuals.


Organ and tissue transplantation often face the challenge of graft rejection, where the recipient's immune system recognizes the transplanted tissue as foreign and attacks it. Cell therapy, particularly through Tregs, offers a potential solution to induce tolerance to the transplanted organ, reducing the risk of rejection and the need for lifelong immunosuppressive medications [10].

Challenges and future prospects

While cell therapy holds great promise, several challenges need to be addressed to ensure its broader implementation and success

Safety and side effects

Cell therapy can trigger severe immune reactions, as seen in CAR-T cell therapy with cytokine release syndrome and neurotoxicity. Careful monitoring and management of these side effects are crucial for patient safety.

Personalized approach

Each patient's immune system is unique, requiring a personalized approach to cell therapy. Developing standardized protocols and manufacturing processes for personalized treatments remains a challenge.

Cost and accessibility

Currently, cell therapy is expensive and often limited to specialized centers. Reducing costs and increasing accessibility to a broader population are essential goals for the future of cell therapy.

Long-term efficacy

Understanding the long-term effects of cell therapy is essential, especially in chronic immunological conditions and cancer remissions. Long-term follow-up studies are necessary to assess the durability and sustainability of treatment outcomes [8-10].


Cell therapy represents a transformative approach in the field of immunology, offering a new ray of hope for patients with various immunological conditions. The continuous efforts of researchers and medical professionals in refining cell therapy techniques, understanding immune responses better, and expanding its applications are paving the way for a future where these cuttingedge treatments may become more accessible and effective. As the field progresses, we can anticipate breakthroughs that will potentially transform the lives of countless individuals living with immunological conditions.


  1. Binod Kumar Deo N S, Rajesh Kumar, Dhana Ratna Shakya (2020) A Study on Pregnancy, Perceived Stress and Depression. JBPKIHS 3:79-87.
  2. Indexed at, Google Scholar, Crossref

  3. Wassapol Thongsomboon K K, Nitchawan Kerdcharoen (2020) Perceived Stress and Associated Factors Among Pregnant Women Attending Antenatal Care in Urban Thailand. Dove Medical Press Ltd.
  4. Google Scholar

  5. Heera Shenoy T R K, Sheela Shenoy T  (2020) Screening for perceived stress among pregnant women availing antenatal care at a tertiary care teaching institution in Kerala, India. Int J Reprod Contracept Obstet Gynecol 9:3279-3230.
  6. Indexed at, Google Scholar, Crossref

  7. Reeta Vijayaselvi M M  B, Anuja Abr aham,  Suja Kurian, Annie Regi, Grace Rebekah (2015)  Risk factors for stress during antenatal period among pregnant women in tertiary care hospital of southern India. J Clin Diagn Res 910.
  8. Indexed at, Google Scholar, Crossref

  9. Silvana Andrea Molina Lima R P E D, Meline Rossetto Kron Rodrigues, Guilherme Augusto Rago Ferraz, Ana Claudia Molina (2018)  Is the risk of low birth weight or preterm labor greater when maternal stress is experienced during pregnancy? A systematic review and meta-analysis of cohort studies.
  10. Indexed at, Google Scholar, Crossref

  11. Pickler RH, Reyna MBA, McCain N, Lewis MM, Cone MS et al (2010) A model of neurodevelopmental risk and protection for preterm infants. J Perinat Neonatal Nurs 24:356.
  12. Indexed at, Google Scholar

  13. Barthelemy Tandu-Umba D K D, Gilbert L (2001) Maternal Stress and Pregnancy Outcomes. Open J Obstet Gynaecol 4:361-370.
  14. Indexed at, Google Scholar, Crossref

  15. Pais M (2018) Stress among pregnant women: a systematic review. J Clin Diagn Res. 12:1-4.
  16. Google Scholar

  17. Nigus Alemnew Engidaw (2019) Perceived stress and its associated factors among pregnant women in Bale zone Hospitals, Southeast Ethiopia. BMC Res Notes 12:356.
  18. Google Scholar, Crossref

  19. Tiara C, Willie A P, Trace Kershaw (2016) Stress in the City: Influence of Urban Social Stress and Violence on Pregnancy and Postpartum Quality of Life among Adolescent and Young Mothers 93:1.
  20. Indexed at, Google Scholar, Crossref

Citation: Odam SG, Shippman J (2023) Cell Therapy Advancements for Immunological Conditions. Health Sci J. Vol. 17 No. 7: 1042.